FDA Peptide Reclassification 2026: What It Means for Providers New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Moves on Peptides: What Compounding Pharmacies Need to Know